This finding supported that the binding efficiencies of SRSF3 and HNRNPH1 to PRMT5 pre-mRNA might influence the level change in PRMT5-ISO5 response to IR treatment in different HCC cells. This evidence concerns the gene SRSF3 and hepatocellular carcinoma.